Faili A - Search Results

1

Convulxin, a potent platelet-aggregating protein from Crotalus durissus terrificus venom, specifically binds to platelets.

Francischetti IM, Saliou B, Leduc M, Carlini CR, Hatmi M, Randon J, Faili A, Bon C. Francischetti IM, et al. Among authors: faili a. Toxicon. 1997 Aug;35(8):1217-28. doi: 10.1016/s0041-0101(97)00021-4. Toxicon. 1997. PMID: 9278971

2

Convulxin-induced platelet aggregation is accompanied by a powerful activation of the phospholipase C pathway.

Faili A, Randon J, Francischetti IM, Vargaftig BB, Hatmi M. Faili A, et al. Biochem J. 1994 Feb 15;298 ( Pt 1)(Pt 1):87-91. doi: 10.1042/bj2980087. Biochem J. 1994. PMID: 8129734 Free PMC article.

3

Dissociation between the phospholipases C and A2 activities in stimulated platelets and their involvement in the arachidonic acid liberation.

Faili A, Emadi S, Vargaftig BB, Hatmi M. Faili A, et al. Br J Haematol. 1994 Sep;88(1):149-55. doi: 10.1111/j.1365-2141.1994.tb04990.x. Br J Haematol. 1994. PMID: 7803237

4

Secretory phospholipase A2 is not required for arachidonic acid liberation during platelet activation.

Mounier C, Faili A, Vargaftig BB, Bon C, Hatmi M. Mounier C, et al. Among authors: faili a. Eur J Biochem. 1993 Aug 15;216(1):169-75. doi: 10.1111/j.1432-1033.1993.tb18129.x. Eur J Biochem. 1993. PMID: 8365403 Free article.

5

Reduction by arachidonic acid of prostaglandin I2-induced cyclic AMP formation. Involvement of prostaglandins E2 and F2 alpha.

Faili A, Randon J, Vargaftig BB, Hatmi M. Faili A, et al. Biochem Pharmacol. 1993 May 5;45(9):1815-20. doi: 10.1016/0006-2952(93)90438-3. Biochem Pharmacol. 1993. PMID: 8388209

6

Competitive inhibition of phospholipase A2 activity by the platelet-activating factor antagonist Ro 19-3704 and evidence for a novel suppressive effect on platelet activation.

Mounier C, Hatmi M, Faili A, Bon C, Vargaftig BB. Mounier C, et al. Among authors: faili a. J Pharmacol Exp Ther. 1993 Mar;264(3):1460-7. J Pharmacol Exp Ther. 1993. PMID: 8450479

7

Carrageenan-induced activation of human platelets is dependent on the phospholipase C pathway.

Hatmi M, Randon J, Faili A, Vargaftig BB. Hatmi M, et al. Among authors: faili a. Br J Haematol. 1993 Feb;83(2):270-5. doi: 10.1111/j.1365-2141.1993.tb08282.x. Br J Haematol. 1993. PMID: 8457475

8

Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse.

Delbos F, De Smet A, Faili A, Aoufouchi S, Weill JC, Reynaud CA. Delbos F, et al. Among authors: faili a. J Exp Med. 2005 Apr 18;201(8):1191-6. doi: 10.1084/jem.20050292. Epub 2005 Apr 11. J Exp Med. 2005. PMID: 15824086 Free PMC article.

9

Hypermutation in human B cells in vivo and in vitro.

Weller S, Faili A, Aoufouchi S, Guéranger Q, Braun M, Reynaud CA, Weill JC. Weller S, et al. Among authors: faili a. Ann N Y Acad Sci. 2003 Apr;987:158-65. doi: 10.1111/j.1749-6632.2003.tb06044.x. Ann N Y Acad Sci. 2003. PMID: 12727635 Review.

10

Proteasomal degradation restricts the nuclear lifespan of AID.

Aoufouchi S, Faili A, Zober C, D'Orlando O, Weller S, Weill JC, Reynaud CA. Aoufouchi S, et al. Among authors: faili a. J Exp Med. 2008 Jun 9;205(6):1357-68. doi: 10.1084/jem.20070950. Epub 2008 May 12. J Exp Med. 2008. PMID: 18474627 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters